GPX6
gene geneOn this page
Summary
GPX6 (glutathione peroxidase 6, HGNC:4558) is a protein-coding gene on chromosome 6p22.1, encoding Glutathione peroxidase 6 (P59796).
The protein encoded by this gene belongs to the glutathione peroxidase family, members of which catalyze the reduction of hydrogen peroxide, organic hydroperoxides and lipid hydroperoxides, and thereby protect cells against oxidative damage. Several isozymes of this gene family exist in vertebrates, which vary in cellular location and substrate specificity. Expression of this gene has been observed in embryos and olfactory epithelium; however, the exact function of this gene is not known. This isozyme is a selenoprotein in humans, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3’ UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. The orthologs of this gene in mouse and rat (and some other species) contain a cysteine (Cys) residue in place of the Sec residue, and their corresponding mRNAs lack SECIS element.
Source: NCBI Gene 257202 — RefSeq curated summary.
At a glance
- GWAS associations: 25
- Clinical variants (ClinVar): 30 total
- MANE Select transcript:
NM_182701
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4558 |
| Approved symbol | GPX6 |
| Name | glutathione peroxidase 6 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198704 |
| Ensembl biotype | protein_coding |
| OMIM | 607913 |
| Entrez | 257202 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000361902, ENST00000474923, ENST00000483058
RefSeq mRNA: 1 — MANE Select: NM_182701
NM_182701
CCDS: CCDS43432
Canonical transcript exons
ENST00000361902 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001434684 | 28503296 | 28504498 |
| ENSE00001436844 | 28506312 | 28506429 |
| ENSE00001473230 | 28515657 | 28515793 |
| ENSE00001963153 | 28505703 | 28505802 |
| ENSE00003590503 | 28510751 | 28510904 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 85.72.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.8313 / max 121.1757, expressed in 1350 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2878 | 13.8313 | 1350 |
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.72 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.77 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 50.30 | gold quality |
| sural nerve | UBERON:0015488 | 49.41 | gold quality |
| right testis | UBERON:0004534 | 38.30 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| apex of heart | UBERON:0002098 | 35.76 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.66 | gold quality |
| granulocyte | CL:0000094 | 35.50 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| testis | UBERON:0000473 | 35.48 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 34.56 | gold quality |
| left testis | UBERON:0004533 | 34.54 | silver quality |
| leukocyte | CL:0000738 | 32.80 | silver quality |
| monocyte | CL:0000576 | 32.75 | silver quality |
| muscle tissue | UBERON:0002385 | 31.93 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.37 | gold quality |
| liver | UBERON:0002107 | 29.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.85 | gold quality |
| cortex of kidney | UBERON:0001225 | 28.82 | gold quality |
| tonsil | UBERON:0002372 | 28.73 | gold quality |
| uterine cervix | UBERON:0000002 | 28.28 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| kidney | UBERON:0002113 | 28.10 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
58 targeting GPX6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-329-3P | 99.91 | 66.56 | 1234 |
| HSA-MIR-362-3P | 99.91 | 66.38 | 1267 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
Literature-anchored findings (GeneRIF, showing 1)
- Association between genetic variants in oxidative stress-related genes and osteoporotic bone fracture. The Hortega follow-up study. (PMID:34688818)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gpx4a | ENSDARG00000068478 |
| mus_musculus | Gpx6 | ENSMUSG00000004341 |
| rattus_norvegicus | Gpx6 | ENSRNOG00000060749 |
| caenorhabditis_elegans | WBGENE00007516 | |
| caenorhabditis_elegans | WBGENE00007517 | |
| caenorhabditis_elegans | WBGENE00011045 | |
| caenorhabditis_elegans | gpx-8 | WBGENE00018850 |
| caenorhabditis_elegans | WBGENE00022377 |
Paralogs (7): GPX7 (ENSG00000116157), GPX8 (ENSG00000164294), GPX4 (ENSG00000167468), GPX2 (ENSG00000176153), GPX3 (ENSG00000211445), GPX5 (ENSG00000224586), GPX1 (ENSG00000233276)
Protein
Protein identifiers
Glutathione peroxidase 6 — P59796 (reviewed: P59796)
All UniProt accessions (2): P59796, A0A182DWH6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Tissue specificity. Expressed in olfactory epithelium and embryos.
Similarity. Belongs to the glutathione peroxidase family.
RefSeq proteins (1): NP_874360* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000889 | Glutathione_peroxidase | Family |
| IPR029759 | GPX_AS | Active_site |
| IPR029760 | GPX_CS | Conserved_site |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
Pfam: PF00255
Enzyme classification (BRENDA):
- EC 1.11.1.9 — glutathione peroxidase (BRENDA: 58 organisms, 96 substrates, 65 inhibitors, 63 Km, 23 kcat entries)
Substrate kinetics (BRENDA)
12 substrates with measured Km, best-characterized 12. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| H2O2 | 0.0023–19.08 | 19 |
| GSH | 0.033–11.1 | 18 |
| CUMENE HYDROPEROXIDE | 0.006–7.8 | 6 |
| TERT-BUTYL HYDROPEROXIDE | 0.059–7.9 | 6 |
| GLUTATHIONE | 0.022–1.73 | 4 |
| CUMENE PEROXIDE | 0.09–0.42 | 2 |
| L-ALPHA-PHOSPHATIDYLCHOLINE HYDROPEROXIDE | 0.026–9.7 | 2 |
| LINOLENIC ACID HYDROPEROXIDE | 0.007–3.8 | 2 |
| CHOLESTEROL 5ALPHA-HYDROPEROXIDE | 0.004 | 1 |
| CHOLESTEROL 7ALPHA-HYDROPEROXIDE | 0.011 | 1 |
| CHOLESTEROL 7BETA-HYDROPEROXIDE | 0.003 | 1 |
| TERT-BUTYLHYDROPEROXIDE | 0.024 | 1 |
Catalyzed reactions (Rhea), 1 shown:
- 2 glutathione + H2O2 = glutathione disulfide + 2 H2O (RHEA:16833)
UniProt features (14 total): sequence variant 10, signal peptide 1, chain 1, active site 1, non-standard amino acid 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
No AlphaFold model available for P59796 — AlphaFold DB does not currently provide models for proteins above ~3000 aa.
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 73
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-3299685 | Detoxification of Reactive Oxygen Species |
MSigDB gene sets: 50 (showing top):
GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5, GOBP_DETOXIFICATION, GOMF_ANTIOXIDANT_ACTIVITY, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR, GOBP_RESPONSE_TO_TOXIC_SUBSTANCE, GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY, KEGG_GLUTATHIONE_METABOLISM, YOSHIMURA_MAPK8_TARGETS_UP, REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES, ESC_J1_UP_EARLY.V1_UP, REACTOME_CELLULAR_RESPONSES_TO_STIMULI, GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS, MIR8485, MIR4306
GO Biological Process (2): response to oxidative stress (GO:0006979), cellular oxidant detoxification (GO:0098869)
GO Molecular Function (3): glutathione peroxidase activity (GO:0004602), peroxidase activity (GO:0004601), oxidoreductase activity (GO:0016491)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Cellular response to chemical stress | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| response to stress | 1 |
| cellular detoxification | 1 |
| peroxidase activity | 1 |
| antioxidant activity | 1 |
| oxidoreductase activity, acting on peroxide as acceptor | 1 |
| catalytic activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
3286 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPX6 | GSR | P00390 | 967 |
| GPX6 | TXN | P10599 | 896 |
| GPX6 | XDH | P47989 | 884 |
| GPX6 | SOD2 | P04179 | 851 |
| GPX6 | F5H3C5 | F5H3C5 | 850 |
| GPX6 | GLRX | P35754 | 841 |
| GPX6 | HMOX1 | P09601 | 838 |
| GPX6 | TXNRD1 | Q16881 | 833 |
| GPX6 | SOD1 | P00441 | 816 |
| GPX6 | H6PD | O95479 | 804 |
| GPX6 | G6PD | P11413 | 804 |
| GPX6 | GPT | P24298 | 802 |
| GPX6 | NFE2L2 | Q16236 | 795 |
| GPX6 | TXNRD3 | Q86VQ6 | 776 |
| GPX6 | MSRB1 | Q9NZV6 | 771 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1Q3EPF5, A0A2Z5VKM8, A0AAW1I778, A1KV41, B3EWI1, E3W9M2, G9JJU2, O16580, O18994, O75715, O77404, P06610, P07191, P07192, P0A0T4, P0A0T5, P0C2T0, P0CU34, P10901, P28714, P28843, P30710, P34760, P35666, P36014, P36973, P48822, P52033, P59796, P67877, P67878, P80602, Q04120, Q59WD3, Q5HKZ3, Q5N863, Q69TH4, Q69TI0, Q69TI2, Q6Y0Z3
Diamond homologs: A1KV41, G9JJU2, O02621, O04922, O18994, O22448, O22850, O23814, O23968, O23970, O24031, O24296, O32770, O46607, O48646, O49069, O59858, O62327, O70325, O75715, P00435, P04041, P06610, P07203, P0A0T4, P0A0T5, P0C2T0, P11352, P11909, P18283, P21765, P22352, P23764, P28714, P30708, P30710, P35666, P36014, P36968, P36969
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
511 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:28506310:A:AC | donor_gain | 1.0000 |
| 6:28506311:C:CC | donor_gain | 1.0000 |
| 6:28504512:A:C | acceptor_gain | 0.9900 |
| 6:28504730:T:TA | donor_gain | 0.9900 |
| 6:28504733:T:TA | donor_gain | 0.9900 |
| 6:28504739:C:A | donor_gain | 0.9900 |
| 6:28506313:TGAG:T | donor_gain | 0.9900 |
| 6:28510762:G:C | donor_gain | 0.9900 |
| 6:28510900:TCCAC:T | acceptor_gain | 0.9900 |
| 6:28510901:CCACC:C | acceptor_gain | 0.9900 |
| 6:28510903:ACCT:A | acceptor_loss | 0.9900 |
| 6:28510904:CCTGG:C | acceptor_loss | 0.9900 |
| 6:28510905:CTGG:C | acceptor_loss | 0.9900 |
| 6:28510906:T:G | acceptor_loss | 0.9900 |
| 6:28510913:T:C | acceptor_gain | 0.9900 |
| 6:28510913:T:TC | acceptor_gain | 0.9900 |
| 6:28504738:T:A | donor_gain | 0.9800 |
| 6:28504748:T:A | donor_gain | 0.9800 |
| 6:28506303:AGCAC:A | donor_loss | 0.9800 |
| 6:28506304:GCAC:G | donor_loss | 0.9800 |
| 6:28506305:CACTC:C | donor_loss | 0.9800 |
| 6:28506306:ACTCA:A | donor_loss | 0.9800 |
| 6:28506307:C:A | donor_loss | 0.9800 |
| 6:28506308:TCA:T | donor_loss | 0.9800 |
| 6:28506309:C:CT | donor_loss | 0.9800 |
| 6:28506310:ACT:A | donor_loss | 0.9800 |
| 6:28506311:C:CA | donor_loss | 0.9800 |
| 6:28506425:CAGTT:C | acceptor_gain | 0.9800 |
| 6:28506430:C:CC | acceptor_gain | 0.9800 |
| 6:28510901:CCAC:C | acceptor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000073950 (6:28512026 G>A,C), RS1000085202 (6:28514457 C>G,T), RS1000297654 (6:28514200 A>G), RS1000594187 (6:28506052 T>C), RS1000870997 (6:28517681 G>T), RS1000902954 (6:28515375 CA>C), RS1000923380 (6:28517318 G>C,T), RS1001454997 (6:28513168 G>A), RS1001833703 (6:28503580 T>C), RS1001834318 (6:28513450 C>G,T), RS1001842070 (6:28512054 C>T), RS1001909788 (6:28503232 T>A,G), RS1002002624 (6:28505865 C>T), RS1002181228 (6:28503776 G>A,C), RS1002315613 (6:28512536 A>C)
Disease associations
OMIM: gene MIM:607913 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
25 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002748_15 | Epithelial ovarian cancer | 6.000000e-06 |
| GCST002748_20 | Epithelial ovarian cancer | 3.000000e-08 |
| GCST003518_56 | Daytime sleep phenotypes | 2.000000e-07 |
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_166 | Autism spectrum disorder or schizophrenia | 4.000000e-24 |
| GCST004521_212 | Autism spectrum disorder or schizophrenia | 5.000000e-14 |
| GCST004521_43 | Autism spectrum disorder or schizophrenia | 2.000000e-27 |
| GCST004521_7 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_73 | Autism spectrum disorder or schizophrenia | 8.000000e-11 |
| GCST004521_77 | Autism spectrum disorder or schizophrenia | 1.000000e-19 |
| GCST004750_42 | Squamous cell lung carcinoma | 2.000000e-10 |
| GCST006575_10 | Takayasu arteritis | 5.000000e-06 |
| GCST008921_4 | Asthma and major depressive disorder | 2.000000e-11 |
| GCST010002_50 | Refractive error | 4.000000e-34 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
| GCST012226_450 | Waist circumference adjusted for body mass index | 2.000000e-08 |
| GCST90020028_837 | Hip circumference adjusted for BMI | 3.000000e-08 |
| GCST90020028_839 | Hip circumference adjusted for BMI | 2.000000e-12 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| lasiocarpine | decreases expression | 1 |
| bisphenol A | affects methylation, affects cotreatment, increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Quercetin | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): malignant epithelial tumor of ovary, Takayasu arteritis